Owing to the increasing appreciation of the importance of aberrant epigenetic states in cancer, and the overexpression of various HDACs in many cancer types, HDAC inhibitors have been extensively ...

LBH589 is a novel pan-histone deacetylase (HDAC) inhibitor that has potent antitumor activity in multiple myeloma and other hematological malignancies. However, its impact on the immune system has ...

This manuscript demonstrates that Oct4 overexpression synergizes with Notch inhibition (Rbpj knockout) to promote the conversion of adult murine Müller glia (MG) into bipolar cells. These findings are ...